Kidney filter study tests safer dialysis for acute kidney failure
NCT ID NCT07679568
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study looks at how well a specific kidney filter (multiFlux 160) works when used with two different blood thinners—heparin or citrate—during continuous kidney replacement therapy. The goal is to see which approach keeps the filter working effectively while avoiding side effects like electrolyte imbalances. The study includes adults and children with acute kidney injury who need this therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
multiFlux 160 hemofilter
What this could lead to
If successful, this study could help doctors choose the best blood thinner for kidney dialysis in critically ill patients, potentially improving treatment safety and effectiveness.
What could go wrong
This is a small observational study, not a large trial. It cannot prove which approach is better overall, and results may not apply to all patients with kidney injury.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinikum der Ludwig-Maximilians-Universität München (LMU Klinikum)
Munich, Bavaria, 81377, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••